Banco de Sabadell S.A Has $3.55 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Banco de Sabadell S.A grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,006 shares of the healthcare conglomerate’s stock after buying an additional 92 shares during the quarter. UnitedHealth Group accounts for about 2.8% of Banco de Sabadell S.A’s holdings, making the stock its 11th biggest position. Banco de Sabadell S.A’s holdings in UnitedHealth Group were worth $3,546,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $25,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group during the 4th quarter valued at $30,000. Promus Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth $32,000. RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group during the third quarter valued at about $37,000. Finally, Pillar Financial Advisors LLC bought a new stake in UnitedHealth Group in the 4th quarter worth about $40,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on UNH. KeyCorp reaffirmed an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Deutsche Bank Aktiengesellschaft raised their target price on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Finally, HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a report on Friday, January 10th. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $629.32.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Up 1.3 %

Shares of UnitedHealth Group stock opened at $517.72 on Friday. The company’s 50-day moving average price is $510.19 and its 200-day moving average price is $547.11. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $473.57 billion, a price-to-earnings ratio of 33.40, a PEG ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the prior year, the firm posted $5.83 earnings per share. The business’s quarterly revenue was up 6.8% on a year-over-year basis. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.